Deerfield Management Company, L.P. (Series C) Ideaya Biosciences, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 2,594,000 shares of IDYA stock, worth $71.2 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
2,594,000
Previous 2,097,113
23.69%
Holding current value
$71.2 Million
Previous $73.6 Million
11.61%
% of portfolio
1.53%
Previous 1.55%
Shares
8 transactions
Others Institutions Holding IDYA
# of Institutions
216Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$187 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$143 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$142 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$132 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$110 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.32B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...